» Articles » PMID: 35495253

Exploring the Inhibitory Mechanism of Piceatannol on α-glucosidase Relevant to Diabetes Mellitus

Overview
Journal RSC Adv
Specialty Chemistry
Date 2022 May 2
PMID 35495253
Authors
Affiliations
Soon will be listed here.
Abstract

Due to their association with type 2 diabetes mellitus treatment, α-glucosidase inhibitors have attracted increasing attention of researchers. In this study, we systemically investigated the kinetics and inhibition mechanism of piceatannol on α-glucosidase. Enzyme kinetics analyses showed that piceatannol exhibited strong inhibition on α-glucosidase in a non-competitive manner. Spectroscopy analyses indicated that piceatannol could bind with α-glucosidase to form complexes high affinity. Further, computational molecular dynamics and molecular docking studies validated that the binding of piceatannol was outside the catalytic site of α-glucosidase, which would induce conformational changes of α-glucosidase and block the entrance of substrate, causing declines in α-glucosidase activities. Our results provide useful information not only for the inhibition mechanism of piceatannol against α-glucosidase but also for a novel target site for developing novel α-glucosidase inhibitors as potential therapeutic agents in the treatment of type 2 diabetes mellitus.

Citing Articles

Mechanistic study of α-mangostin derivatives as potent α-glucosidase inhibitors.

Sanachai K, Chamni S, Nutho B, Khammuang S, Ratha J, Choowongkomon K Mol Divers. 2025; .

PMID: 39994156 DOI: 10.1007/s11030-025-11141-6.


Aubl. Essential Oil: Chemical Composition, In Vitro Antioxidant Activity, and Inhibitory Effects of Acetylcholinesterase, α-Glucosidase and β-Lactamase.

Zhu X, Zhu J, Xu Z, Liu X Molecules. 2024; 29(12).

PMID: 38930934 PMC: 11206966. DOI: 10.3390/molecules29122869.


Piceatannol: a renaissance in antibacterial innovation unveiling synergistic potency and virulence disruption against serious pathogens.

Koshak A, Elfaky M, Albadawi D, Abdallah H, Mohamed G, Ibrahim S Int Microbiol. 2024; 28(2):213-225.

PMID: 38767683 DOI: 10.1007/s10123-024-00532-8.


Potential -Glucosidase Inhibitors from the Deep-Sea Sediment-Derived Fungus .

Zhao W, Zeng Y, Chang W, Chen H, Wang H, Dai H Mar Drugs. 2023; 21(3).

PMID: 36976206 PMC: 10056930. DOI: 10.3390/md21030157.


Antidiabetic, Antiglycation, and Antioxidant Activities of Ethanolic Seed Extract of and Piceatannol In Vitro.

Dos Santos F, Xavier J, da Silva F, Merlin J, Goulart M, Rupasinghe H Molecules. 2022; 27(13).

PMID: 35807309 PMC: 9267955. DOI: 10.3390/molecules27134064.

References
1.
Poongunran J, Perera H, Jayasinghe L, Fernando I, Sivakanesan R, Araya H . Bioassay-guided fractionation and identification of α-amylase inhibitors from Syzygium cumini leaves. Pharm Biol. 2016; 55(1):206-211. PMC: 6130705. DOI: 10.1080/13880209.2016.1257031. View

2.
He H, Lu Y . Comparison of inhibitory activities and mechanisms of five mulberry plant bioactive components against α-glucosidase. J Agric Food Chem. 2013; 61(34):8110-9. DOI: 10.1021/jf4019323. View

3.
Tong D, Zhu K, Guo X, Peng W, Zhou H . The enhanced inhibition of water extract of black tea under baking treatment on α-amylase and α-glucosidase. Int J Biol Macromol. 2017; 107(Pt A):129-136. DOI: 10.1016/j.ijbiomac.2017.08.152. View

4.
Yue L, Lee J, Zheng L, Park Y, Ye Z, Yang J . Computational prediction integrating the inhibition kinetics of gallotannin on α-glucosidase. Int J Biol Macromol. 2017; 103:829-838. DOI: 10.1016/j.ijbiomac.2017.05.106. View

5.
Uchida-Maruki H, Inagaki H, Ito R, Kurita I, Sai M, Ito T . Piceatannol lowers the blood glucose level in diabetic mice. Biol Pharm Bull. 2015; 38(4):629-33. DOI: 10.1248/bpb.b15-00009. View